Prescriber Attitudes, Experiences, and Proclivities Toward Digital Medicine and How They Influence Adoption of Digital Medicine Platforms.
Liberman, Joshua N
Velligan, Dawn I
JournalNeuropsychiatric Disease and Treatment
MetadataShow full item record
AbstractBackground: Psychiatric prescribers (prescribers) typically assess medication adherence by patient or caregiver self-report. Despite likely clinical benefit of a new digital medicine technology, the role of specific prescriber attitudes, behaviors, and experiences in the likelihood of adoption is unclear. Objective: To identify prescriber characteristics that may affect adoption of the ingestible event marker (IEM) platform. Design: A survey of prescribers treating seriously mentally ill patients was conducted. Factor analysis was performed on 11 items representing prescriber characteristics believed to be related to endorsement of the IEM platform. Four factors were extracted. Regression analysis was used to test the strength of the relationships between the factors and likelihood of adoption of the IEM platform. Results: A total of 131 prescribers completed the survey. Most (84%) agreed that visits allow enough time to monitor adherence. Factor analysis revealed four underlying dimensions: 1) perspectives on the value of adherence; 2) concerns about measuring adherence; 3) views toward digital health technologies; and 4) views on payer role/reimbursement. Factors 1 and 3 were related to gender, the belief that computerization benefits prescribers, the presence of office support staff, and the belief that new digital medicine (DM) technology will be cost prohibitive. Willingness to adopt the IEM platform was related to gender (p < 0.05) and perspectives on the value of adherence (p < 0.05), with those scoring higher on that measure also being more likely to adopt. Conclusion: Psychiatric prescribers are concerned about medication adherence, perceive current monitoring tools to be problematic, and are open to using digital technologies to improve accuracy of adherence assessment. Relationships among prescriber characteristics, beliefs, and experiences should be considered when developing educational materials, particularly when the goal is to encourage adoption and use of the IEM platform.
Rights/Terms© 2021 Ruetsch et al.
digital health technologies
Identifier to cite or link to this itemhttp://hdl.handle.net/10713/17581
- Evaluation of prescriber responses to pharmacist recommendations communicated by fax in a medication therapy management program (MTMP).
- Authors: Perera PN, Guy MC, Sweaney AM, Boesen KP
- Issue date: 2011 Jun
- Are caregivers ready for digital? Caregiver preferences for health technology tools to monitor medication adherence among patients with serious mental illness.
- Authors: Forma F, Chiu K, Shafrin J, Boskovic DH, Veeranki SP
- Issue date: 2022 Jan-Dec
- Continuity of antipsychotic medication management for Medicaid patients with schizophrenia.
- Authors: Farley JF, Wang CC, Hansen RA, Voils CI, Maciejewski ML
- Issue date: 2011 Jul
- Mental Health Care Provider's Perspectives Toward Adopting a Novel Technology to Improve Medication Adherence.
- Authors: Liberman JN, Davis T, Velligan D, Robinson D, Carpenter W, Jaeger C, Waters H, Ruetsch C, Forma F
- Issue date: 2022 Summer
- Attitudes, Beliefs, and Willingness Toward the Use of mHealth Tools for Medication Adherence in the Florida mHealth Adherence Project for People Living With HIV (FL-mAPP): Pilot Questionnaire Study.
- Authors: Morano JP, Clauson K, Zhou Z, Escobar-Viera CG, Lieb S, Chen IK, Kirk D, Carter WM, Ruppal M, Cook RL
- Issue date: 2019 Jul 3